|
Randomized phase II study of docetaxel (D) + abiraterone acetate (AA) versus D after disease progression to first-line AA in metastatic castration-resistant prostate cancer (mCRPC): ABIDO-SOGUG Trial. |
|
Miguel Angel Climent Duran |
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Janssen-Cilag; Merck; Pfizer; Roche/Genentech; Sanofi |
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen |
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche/Genentech |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi |
Research Funding - Astellas Pharma; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi |
Research Funding - Janssen Oncology (Inst) |
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
Maria Jose José Mendez Vidal |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Janssen-Cilag; MSD Oncology; Novartis |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer |
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer |
|
Aranzazu Gonzalez del Alba |
Honoraria - Astellas Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi/Aventis |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Speakers' Bureau - Ipsen; Janssen-Cilag; Pfizer; Pierre Fabre; Roche |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; PFIZER; Roche; Sanofi |
|
Alfredo Sanchez-Hernandez |
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi |
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Roche; Sanofi |
|
|
Travel, Accommodations, Expenses - Pfizer/EMD Serono; Pfizer/EMD Serono |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi |
|
Travel, Accommodations, Expenses - Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
Martín Emilio Lázaro Quintela |
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Merck Sharp & Dohme; Roche |
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche; Sanofi |
Research Funding - Astellas Pharma; Bayer; Janssen; Roche; Sanofi |
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer; Roche |